OncoSil Medical Limited Price (OSL.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

2,219,392,243

(85.5617)%

OncoSil Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorpora... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.004-0.015
  • Market Cap 23.03M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Devices

  • ceo: Mr. Nigel Lange
  • IPO Date: August, 15, 2005
  • Country: AU
  • Currency: AUD
  • Headquaters: North Sydney, NSW
  • Employees: 2

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation